Angel maintains BUY rating on Sun Pharma despite 11 US FDA observations
Most Popular (6 hours)

Modi leaves for three-nation tour

- punjabnewsexpress.com

Amy Poehler hates gambling

- business-standard

Deadmau5 hates The Chainsmokers

- business-standard

Yasin Malik arrested in Srinagar

- punjabnewsexpress.com

Most Popular (24 hours)

India to get 22 Guardian drones

- kaumudiglobal.com

Pegasus spyware may hit iPhones too

- punjabnewsexpress.com

Shivalik Rasayan to hold EGM

- business-standard

SNM donates 103 units of blood

- dailyexcelsior.com

Most Popular (a week)

Eva Longoria is back as Gabrielle

- heshillongtimes.com

Angel maintains BUY rating on Sun Pharma despite 11 US FDA observations

Angel Broking maintained its BUY rating on Sun Pharmaceutical Industries with a price target of Rs 847, even as the pharma major received 11 observations the US Food and Drug Administration (FDA) for its Dadra unit. The post Angel maintains BUY rating on S

Read on the original site


Lobia slides on subdued demand

- business-standard

ICHR s member secretary resigns

- business-standard
Hashtags:   

Angel

 | 

maintains

 | 

BUY

 | 

rating

 | 

Sun

 | 

Pharma

 | 

despite

 | 

FDA

 | 

observations

 |